Fast Five Quiz: Precision Medicine in Cancer

Winston W. Tan, MD


July 15, 2021

Some genetic mutations can significantly alter the choice of treatment or signal that a cancer is more likely to become resistant to a treatment. In colorectal cancers, mutations in the KRAS gene may signal that a patient will not respond to drugs such as cetuximab or panitumumab.

Learn more about targeting KRAS.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.